Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Numark top OTCs include Equalactin, Certain Dri, Benzedrex with Menley & James assets.

This article was originally published in The Tan Sheet

Executive Summary

NUMARK TOP OTCs INCLUDE EQUALACTIN, CERTAIN DRI, BENZEDREX with the acquisition of essentially all the assets and liabilities of Horsham, Penn.- based Menley & James for approximately $12.9 mil. in cash ("The Tan Sheet" Aug. 24, In Brief). Edison, N.J.-based Numark Labs said of its current brands, the top sellers are Equalactin chewable diarrheal tablets and Certain Dri deodorant/antiperspirants. Menley & James has been focusing its marketing efforts primarily on the Benzedrex decongestant inhaler, as well as Humibid Guaifenesin Plus cough/cold product and Derifil, an internal deodorant.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088800

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel